Literature DB >> 18024699

Tacrolimus induced leukoencephalopathy presenting with status epilepticus and prolonged coma.

Mithri R Junna, Alejandro A Rabinstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18024699      PMCID： PMC2095620          DOI： 10.1136/jnnp.2007.121806

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  5 in total

1.  Recurrent reversible cerebral edema after long term immunosuppression with tacrolimus.

Authors:  Manuela Reinohs; Torsten Straube; Petra Baum; Jörg Berrouschot; Armin Wagner
Journal:  J Neurol       Date:  2002-06       Impact factor: 4.849

2.  Tacrolimus leukoencephalopathy: a neuropathologic confirmation.

Authors:  Catherine M Lavigne; David A Shrier; Manoj Ketkar; James M Powers
Journal:  Neurology       Date:  2004-09-28       Impact factor: 9.910

Review 3.  Neurotoxicity of immunosuppressive drugs.

Authors:  E F Wijdicks
Journal:  Liver Transpl       Date:  2001-11       Impact factor: 5.799

4.  MRI in seven cases of tacrolimus (FK-506) encephalopathy: utility of FLAIR and diffusion-weighted imaging.

Authors:  M Furukawa; S Terae; B C Chu; K Kaneko; H Kamada; K Miyasaka
Journal:  Neuroradiology       Date:  2001-08       Impact factor: 2.804

5.  Tacrolimus toxicity associated with concomitant metoclopramide therapy.

Authors:  William A Prescott; Brian L Callahan; Jeong M Park
Journal:  Pharmacotherapy       Date:  2004-04       Impact factor: 4.705
  5 in total
  10 in total

1.  Cerebral adenovirus endotheliitis presenting as posterior reversible encephalopathy syndrome after allogeneic stem cell transplantation.

Authors:  J-S Claveau; R LeBlanc; I Ahmad; J Ferreira; A-A Pistono; N Bambace; L Bernard; S Cohen; J-S Delisle; T Kiss; S Lachance; J Roy
Journal:  Bone Marrow Transplant       Date:  2017-07-10       Impact factor: 5.483

2.  Refractory status epilepticus secondary to atypical Rasmussen encephalitis successfully managed with aggressive immunotherapy.

Authors:  Sung-Min Cho; Andrew Zeft; Elia Pestana Knight; Prakash Kotagal; Elaine Wyllie; Ahsan N V Moosa
Journal:  Neurol Clin Pract       Date:  2017-02

Review 3.  Neurologic Complications of Transplantation.

Authors:  Rajat Dhar
Journal:  Neurocrit Care       Date:  2018-02       Impact factor: 3.210

4.  Chemotherapy-related posterior reversible leukoencephalopathy syndrome.

Authors:  Archit Bhatt; Muhammad U Farooq; Arshad Majid; Mounzer Kassab
Journal:  Nat Clin Pract Neurol       Date:  2009-03

5.  Neurological variability in chemotherapy-induced posterior reversible encephalopathy syndrome associated with thrombotic microangiopathy: Case reports and literature review.

Authors:  Chen Makranz; Salome Khutsurauli; Yosef Kalish; Ruth Eliahou; Luna Kadouri; John Moshe Gomori; Alexander Lossos
Journal:  Mol Clin Oncol       Date:  2017-11-02

6.  Tacrolimus associated thrombotic thrombocytopenic purpura (TTP) and stroke in the young.

Authors:  Boby Varkey Maramattom; Rahul Patil; Punnoose Thomas; Binu Upendran
Journal:  Ann Indian Acad Neurol       Date:  2015 Jan-Mar       Impact factor: 1.383

7.  Immunosuppressant-associated neurotoxicity responding to olanzapine.

Authors:  James A Bourgeois; Ana Hategan
Journal:  Case Rep Psychiatry       Date:  2014-07-09

8.  Posterior Reversible Encephalopathy Syndrome (PRES) as a Complication of Immunosuppressive Therapy in Renal Transplantation in Children.

Authors:  Emir Hodzic; Majda Brcic; Mirza Atic; Alma Halilcevic; Amila Jasarevic; Mirna Aleckovic-Halilovic; Davor Trojak; Nedima Atic; Snezana Zulic; Zlatan Mehmedovic; Ivana Iveljic
Journal:  Med Arch       Date:  2014-05-31

9.  Immunosuppression-associated posterior reversible encephalopathy syndrome in an acute leukemia case.

Authors:  Umit Y Malkan; Gursel Gunes; Haluk Demiroglu; Hakan Goker
Journal:  Hematol Rep       Date:  2018-11-06

10.  A Rare Case of Cyclophosphamide-Induced Posterior Reversible Encephalopathy Syndrome in a Patient with Anti-GBM Vasculitis, and Review of Current Literature.

Authors:  Taha Nisar; Abdul R Alchaki; Erin Feinstein
Journal:  Case Rep Neurol Med       Date:  2019-09-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.